Michael Wagner

@MichiWagner4
966 Followers
76 Following
31 Posts
Microbiologist, Professor at University of Vienna, Austria
Distinguished Professor at Aalborg University, Denmark
Gestational diabetes is driven by microbiota-induced inflammation months before diagnosis

Objective Gestational diabetes mellitus (GDM) is a condition in which women without diabetes are diagnosed with glucose intolerance during pregnancy, typically in the second or third trimester. Early diagnosis, along with a better understanding of its pathophysiology during the first trimester of pregnancy, may be effective in reducing incidence and associated short-term and long-term morbidities. Design We comprehensively profiled the gut microbiome, metabolome, inflammatory cytokines, nutrition and clinical records of 394 women during the first trimester of pregnancy, before GDM diagnosis. We then built a model that can predict GDM onset weeks before it is typically diagnosed. Further, we demonstrated the role of the microbiome in disease using faecal microbiota transplant (FMT) of first trimester samples from pregnant women across three unique cohorts. Results We found elevated levels of proinflammatory cytokines in women who later developed GDM, decreased faecal short-chain fatty acids and altered microbiome. We next confirmed that differences in GDM-associated microbial composition during the first trimester drove inflammation and insulin resistance more than 10 weeks prior to GDM diagnosis using FMT experiments. Following these observations, we used a machine learning approach to predict GDM based on first trimester clinical, microbial and inflammatory markers with high accuracy. Conclusion GDM onset can be identified in the first trimester of pregnancy, earlier than currently accepted. Furthermore, the gut microbiome appears to play a role in inflammation-induced GDM pathogenesis, with interleukin-6 as a potential contributor to pathogenesis. Potential GDM markers, including microbiota, can serve as targets for early diagnostics and therapeutic intervention leading to prevention. Data are available in a public, open access repositories. All sequencing data were submitted to EBI (project accession number ERP143097). Metabolomics data were deposited at 10.5281/zenodo.6581068.

Gut
Excess deaths in 2022 among worst in 50 years

New figures show more than 650,000 people died in the UK last year.

BBC News

"RSV-infizierte Kinder 2022: 19,2 % mir früherer dokumentierter COVID-19-Infektion, deutlich mehr als die 9,7 % der nicht infizierten Kinder => frühere COVID-19-Infektion Risikofaktor für RSV-Infektion o. gemeinsame Risikofaktoren für beide Infektionen"

"Preprint"

https://www.medrxiv.org/content/10.1101/2022.11.29.22282887v1

Andreas Richter, professor and soil ecologist at our Centre for Microbiology and Environmental Systems Science at the University of Vienna, receives the Philipp Duchaufour Medal 2023. The medal is awarded by the European Geosciences Union (EGU) and is considered the highest award in the field of soils science. The EGU is the leading organization for earth, planetary and space science research in Europe and has about 18,000 members from all over the world.

https://ter.csb.univie.ac.at/news/philipp-duchaufour-medal-2023

Philipp Duchaufour Medal 2023 | Terrestrial Ecosystem Research, University of Vienna

Andreas Richter, professor and soil ecol

Spannende Daten - Medikament zur Behandlung von Lebererkrankungen kann SARS-CoV-2-Infektion hemmen

"UDCA ist weit verbreitet, leicht zugänglich, kosteneffizient, patentfrei und leicht herzustellen"

https://www.nature.com/articles/d41586-022-04149-7

A liver drug reduces SARS-CoV-2 entry into cells

UDCA, a drug commonly used for liver conditions, could protect people who do not have access to vaccines and those with a weak immune system from severe COVID-19.

I guess I’m going to start using this more, now that Twitter is becoming both morally and functionally unusable.
OK, I have no clue how to use this but I am now here.

"COVID-19 was associated with a 66% higher risk of incident diabetes"

https://www.nature.com/articles/s41598-022-24185-7

Association of COVID-19 with diabetes: a systematic review and meta-analysis - Scientific Reports

Emerging evidence suggests that coronavirus disease-2019 (COVID-19) may lead to a wide range of post-acute sequelae outcomes, including new onset of diabetes. The aim of this meta-analysis was to estimate the incidence of newly diagnosed diabetes in survivors of COVID-19. We searched MEDLINE, Scopus, Cochrane Central Register of Controlled Trials and the World Health Organization Global Literature on Coronavirus Disease and clinical trial registries for studies reporting the association of COVID-19 and diabetes. Search dates were December 2019–October 16, 2022. Two investigators independently assessed studies for inclusion. Risk of bias was assessed using the Newcastle–Ottawa Scale. We estimated the effect of COVID-19 on incident diabetes by random-effects meta-analyses using the generic inverse variance method. We identified 8 eligible studies consisting of 4,270,747 COVID-19 patients and 43,203,759 controls. Median age was 43 years (interquartile range, IQR 35–49), and 50% were female. COVID-19 was associated with a 66% higher risk of incident diabetes (risk ratio, 1.66; 95% CI 1.38; 2.00). The risk was not modified by age, sex, or study quality. The median risk of bias assessment was 7. In this systematic review and meta-analysis, COVID-19 was associated with higher risk for developing new onset diabetes among survivors. Active monitoring of glucose dysregulation after recovery from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is warranted.

Nature
6) Es ist aber auch bekannt, dass viele Viren das Immunsystem unterdrücken können. Einige virale Infektionen führen zu einer erhöhten Anfälligkeit für bakterielle und virale Sekundärinfektionen und diese Anfälligkeit kann rel. lange anhalten. Die Hypothese, dass eine durchgemachte SARS-CoV-2-Infektion zu einer temporär erhöhten Anfälligkeit für andere Krankheitserreger führt, verdient mehr Forschungsanstrengungen und Aufmerksamkeit.
5) Dies kann aus individueller Sicht aber sogar vorteilhaft sein, da es z.B bei RSV viel weniger risikoreich ist, wenn man sich erst als etwas älteres Kind infiziert.